2-105038108-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_182640.3(MRPS9):c.16G>A(p.Val6Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_182640.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPS9 | NM_182640.3 | c.16G>A | p.Val6Met | missense_variant | 1/11 | ENST00000258455.8 | NP_872578.1 | |
MRPS9 | XM_047445533.1 | c.16G>A | p.Val6Met | missense_variant | 1/7 | XP_047301489.1 | ||
MRPS9-AS2 | NR_110603.1 | n.43+346C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPS9 | ENST00000258455.8 | c.16G>A | p.Val6Met | missense_variant | 1/11 | 1 | NM_182640.3 | ENSP00000258455.3 | ||
MRPS9-AS2 | ENST00000456519.2 | n.43+346C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250636Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135502
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461632Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727086
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.16G>A (p.V6M) alteration is located in exon 1 (coding exon 1) of the MRPS9 gene. This alteration results from a G to A substitution at nucleotide position 16, causing the valine (V) at amino acid position 6 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at